Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Vanda Pharmaceuticals Inc. | w76141e10vq.htm |
EX-31.2 - EX-31.2 - Vanda Pharmaceuticals Inc. | w76141exv31w2.htm |
EX-31.1 - EX-31.1 - Vanda Pharmaceuticals Inc. | w76141exv31w1.htm |
EXHIBIT 32.1
Certification
Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a)
and (b) of Section 1350, Chapter 63 of
Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of section 1350,
chapter 63 of title 18, United States Code), each of
the undersigned officers of Vanda Pharmaceuticals Inc., (the
Company), does hereby certify, to the best of such
officers knowledge, that:
The Quarterly Report on
Form 10-Q
for the quarter ended September 30, 2009 (the
Form 10-Q)
of the Company fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934, and the information contained in the
Form 10-Q
fairly presents, in all material respects, the consolidated
financial condition and results of operations of the Company.
Date: November 4, 2009
|
/s/ Mihael H. Polymeropoulos |
|
Mihael H. Polymeropoulos Chairman and Chief Executive Officer (Principal Executive Officer) |
Date: November 4, 2009
|
/s/ Stephanie R. Irish |
|
Stephanie R. Irish Acting Chief Financial Officer (Principal Financial and Accounting Officer) |
A signed original of this written statement required by
Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and
Exchange Commission (SEC) or its staff upon request. This
certification accompanies the
Form 10-Q
to which it relates, is not deemed filed with the SEC and is not
to be incorporated by reference into any filing of the Company
under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended (whether made before or after
the date of the
Form 10-Q),
irrespective of any general incorporation language contained in
such filing.